Skip to content
Clinical Trials – home

Centre Hospitalier Intercommunal De Poissy Saint Germain

Verifiedinfo

France Residence Les Maisonnees, 10 Rue Du Champ Gaillard, 78300 St Germain En Laye, France

  • 17 trials recruiting
  • Multiple sclerosis · Relapsing multiple sclerosis · Relapsing-remitting multiple sclerosis
  • Adults and children

About Specializations

Centre Hospitalier Intercommunal De Poissy Saint Germain in St Germain En Laye, France specialises in clinical trials of conditions such as Multiple sclerosis, Relapsing multiple sclerosis, Relapsing-remitting multiple sclerosis, Ischaemic stroke, and other specialisations. This site conducts important research.

Main research areas of the site

Female Urogenital Diseases and Pregnancy Complications

At Centre Hospitalier Intercommunal De Poissy Saint Germain, clinical research in pregnancy complications focuses on protecting both mother and baby, especially in women with chronic hypertension and related risks.

  • Prevention of preeclampsia and other maternal-fetal complications in high-risk pregnancies
  • Study of pregnancy associated hypertension and its impact on outcomes such as fetal growth restriction
  • Evaluation of a treatment approach aimed at reducing serious complications during pregnancy and delivery

This work is centered on improving safety in pregnancy and helping clinicians better prevent adverse outcomes for mothers and newborns.

Nervous System Diseases

Research in nervous system diseases at this site includes studies in multiple sclerosis, with attention to long-term disease control and treatment decisions in older patients.

  • Secondary progressive multiple sclerosis and the effect of continuing or stopping disease-modifying therapies
  • Assessment of disability progression in people with stable forms of multiple sclerosis
  • Evidence generation to support treatment planning for patients with limited recent inflammatory activity

The goal is to better understand how to manage chronic neurologic disease while balancing effectiveness, safety, and quality of life.

Neoplasms

The oncology portfolio at Centre Hospitalier Intercommunal De Poissy Saint Germain includes research on follicular lymphoma and breast carcinoma, with a focus on improving survival and treatment selection.

  • Testing new treatment combinations for previously untreated follicular lymphoma
  • Evaluating whether adjuvant chemotherapy improves outcomes in older women with estrogen-receptor positive, HER2-negative breast cancer
  • Studying ways to refine therapy for patients at higher risk of relapse

These trials aim to strengthen cancer care by comparing treatment strategies and identifying approaches that may offer better disease control.

Other Clinical Research Areas

This site also supports research that does not fit neatly into one therapeutic category, including studies focused on postoperative recovery and metabolic support after surgery.

  • Prevention of post-thyroidectomy hypocalcemia after thyroidectomy
  • Evaluation of cholecalciferol supplementation to improve recovery after surgery
  • Research aimed at reducing discomfort, hospital stay, and perioperative burden

These studies reflect a practical interest in improving everyday patient care through better prevention and supportive treatment strategies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Residence Les Maisonnees, 10 Rue Du Champ Gaillard78300 St Germain En LayeFrance
Recruiting now
17 trials
Conditions studied
39
Partner status
Verified

More sites in St Germain En LayeFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

38 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ocrelizumab
  • Sponsor:Novartis Pharma AG
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dimethyl Fumarate
  • Sponsor:Centre Hospitalier Universitaire De Montpellier
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Epinephrine
  • Sponsor:Hopital NOVO
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ocrelizumab
  • Sponsor:F. Hoffmann-La Roche AG
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Nifedipine
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Midazolam
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Omalizumab
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Centre Hospitalier De Versailles

Placenta praevia+1

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Tranexamic Acid
  • Sponsor:Centre Hospitalier Universitaire De Bordeaux
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Meropenem Anhydrous
  • Sponsor:Assistance Publique Hopitaux De Paris
Investigational
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Recombinant Human Surfactant Protein-D
  • Sponsor:Airway Therapeutics Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.